Article
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Journal of hypertension - 1 Mar 2003
Hallberg Pär, Lind Lars, Michaëlsson Karl, Karlsson Julia, Kurland Lisa, Kahan Thomas, Malmqvist Karin, Ohman K Peter, Nyström Fredrik, Melhus Håkan
Abstract excerpt
OBJECTIVE: Hypertension is associated with a number of adverse morphologic and functional changes in the cardiovascular system, including left ventricular (LV) hypertrophy. Studies have demonstrated that bradykinin, through the B2 bradykinin receptor (B2BKR), mediates important cardiovascular eff...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.